Showing results 1 to 1 of 1
| Issue Year | Title | Author(s) | Type | Views | Downloads |
|---|---|---|---|---|---|
| 2020 | Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study | Ferris, R.L.; Haddad, R.; Even, C.; Tahara, M.; Dvorkin, M.; Ciuleanu, T.E.; Clement, P.M.; Mesia, R.; Kutukova, S.; Zholudeva, L.; Daste, A.; Caballero-Daroqui, J.; Keam, B.; Vynnychenko, Ihor Oleksandrovych; Lafond, C.; Shetty, J.; Mann, H.; Fan, J.; Wildsmith, S.; Morsli, N.; Fayette, J.; Licitra, L. | Article | 48280810 | 63330896 |